| Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination E Nemes, H Geldenhuys, V Rozot, KT Rutkowski, F Ratangee, N Bilek, ... New England Journal of Medicine 379 (2), 138-149, 2018 | 682 | 2018 |
| Dominant TNF-α+Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease A Harari, V Rozot, FB Enders, M Perreau, JM Stalder, LP Nicod, ... Nature medicine 17 (3), 372-376, 2011 | 501 | 2011 |
| A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ... Nature 560 (7720), 644-648, 2018 | 262 | 2018 |
| Mycobacterium tuberculosis‐specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease V Rozot, S Vigano, J Mazza‐Stalder, E Idrizi, CL Day, M Perreau, ... European journal of immunology 43 (6), 1568-1577, 2013 | 229 | 2013 |
| Antigen availability shapes T cell differentiation and function during tuberculosis AO Moguche, M Musvosvi, A Penn-Nicholson, CR Plumlee, H Mearns, ... Cell host & microbe 21 (6), 695-706. e5, 2017 | 182 | 2017 |
| Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection E Nemes, V Rozot, H Geldenhuys, N Bilek, S Mabwe, D Abrahams, ... American journal of respiratory and critical care medicine 196 (5), 638-648, 2017 | 153 | 2017 |
| A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans CS Lindestam Arlehamn, DM McKinney, C Carpenter, S Paul, V Rozot, ... PLoS pathogens 12 (7), e1005760, 2016 | 134 | 2016 |
| Combined Use of Mycobacterium tuberculosis–Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis V Rozot, A Patrizia, S Vigano, J Mazza-Stalder, E Idrizi, CL Day, ... Clinical Infectious Diseases 60 (3), 432-437, 2015 | 107 | 2015 |
| A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates MJ Rodo, V Rozot, E Nemes, O Dintwe, M Hatherill, F Little, TJ Scriba PLoS pathogens 15 (3), e1007643, 2019 | 87 | 2019 |
| Lack of Mycobacterium tuberculosis–specific interleukin‐17A–producing CD4+ T cells in active disease M Perreau, V Rozot, HC Welles, F Belluti‐Enders, S Vigano, M Maillard, ... European journal of immunology 43 (4), 939-948, 2013 | 76 | 2013 |
| Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7Rα (CD127) and … C Cellerai, M Perreau, V Rozot, FB Enders, G Pantaleo, A Harari Journal of virology 84 (8), 3868-3878, 2010 | 63 | 2010 |
| Comparison of CyTOF assays across sites: Results of a six-center pilot study MD Leipold, G Obermoser, C Fenwick, K Kleinstuber, N Rashidi, ... Journal of immunological methods 453, 37-43, 2018 | 57 | 2018 |
| T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection M Musvosvi, H Huang, C Wang, Q Xia, V Rozot, A Krishnan, P Acs, ... Nature Medicine 29 (1), 258-269, 2023 | 55 | 2023 |
| Differential Recognition of Mycobacterium tuberculosis–Specific Epitopes as a Function of Tuberculosis Disease History TJ Scriba, C Carpenter, SC Pro, J Sidney, M Musvosvi, V Rozot, ... American journal of respiratory and critical care medicine 196 (6), 772-781, 2017 | 51 | 2017 |
| H1: IC31 vaccination is safe and induces long-lived TNF-α+ IL-2+ CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial H Mearns, HD Geldenhuys, BM Kagina, M Musvosvi, F Little, F Ratangee, ... Vaccine 35 (1), 132-141, 2017 | 51 | 2017 |
| NYVAC immunization induces polyfunctional HIV‐specific T‐cell responses in chronically‐infected, ART‐treated HIV patients A Harari, V Rozot, M Cavassini, FB Enders, S Vigano, G Tapia, E Castro, ... European journal of immunology 42 (11), 3038-3048, 2012 | 47 | 2012 |
| Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection CAM Mpande, M Musvosvi, V Rozot, B Mosito, TD Reid, C Schreuder, ... American Journal of Respiratory and Critical Care Medicine 203 (12), 1556-1565, 2021 | 37 | 2021 |
| A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents C Carpenter, J Sidney, R Kolla, K Nayak, H Tomiyama, C Tomiyama, ... Tuberculosis 95 (6), 713-721, 2015 | 37 | 2015 |
| Allelic resolution NGS HLA typing of Class I and Class II loci and haplotypes in Cape Town, South Africa YR Thorstenson, LE Creary, H Huang, V Rozot, TT Nguyen, F Babrzadeh, ... Human immunology 79 (12), 839-847, 2018 | 28 | 2018 |
| Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection CAM Mpande, V Rozot, B Mosito, M Musvosvi, OB Dintwe, N Bilek, ... EBioMedicine 64, 2021 | 26 | 2021 |
